Gene · 2921
NIH grants2,607
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,061 to 1,080 of 2,607
Download this page as JSON| Grant | Title | CXCL3 papers | Newest fiscal year |
|---|---|---|---|
| R01HL114800 | Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice | 1 | 2021 |
| R01HL135121 | Clinical and Metabolic Signature of Recovered Myocardium in Human Heart Failure | 1 | 2021 |
| R01HL136314 | Defining SMC phenotypes critical in late stage atherosclerosis pathogenesis | 1 | 2021 |
| R01HL136345 | Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes | 1 | 2021 |
| R01HL137779 | A microRNA-target Network in Endothelial DNA Damage and Angiogenesis | 1 | 2021 |
| R01HL137919 | The Interferon-beta (IFN-beta)/SETDB2 Epigenetic Axis Regulates Inflammation And Metabolism In Diabetic Wounds | 1 | 2021 |
| R01HL140357 | Epigenetic Regulation of Immune Pathways in Sarcoidosis | 1 | 2021 |
| R01HL141570 | Perfusable 3D human cardiac constructs for heart regeneration | 1 | 2021 |
| R01HL142084 | Host control mechanisms against K. pneumoniae infection in the lungs | 1 | 2021 |
| R01HL143359 | Mitochondrial Damage-Induced Necroptotic Cell Death in SporadicAscending Thoracic Aortic Aneurysms and Dissections | 1 | 2021 |
| R01HL143803 | MicroRNA regulation of endothelial DNA repair to enhance anti-tumor immunity | 1 | 2021 |
| R01MH115860 | Combined Molecular Excision Therapy (CMET) for Eliminating HIV-1 | 1 | 2021 |
| R01NS096754 | Chromatin Modifications in GBM-Propagating Cells | 1 | 2021 |
| R01NS103434 | Dual Targeting of Brain Tumor Initiating Cells through Inhibition of BMI1 and EZH2 (R01NS103434) | 1 | 2021 |
| R01NS107851 | Autoimmune Mechanisms in Peripheral Neuropathy | 1 | 2021 |
| R01NS107853 | The Translocator Protein (TSPO) and Intracerebral Hemorrhage | 1 | 2021 |
| R03AI151769 | Novel knockout models to analyze CD38 function | 1 | 2021 |
| R21AG064899 | Mechanistic basis of inflammation in Alzheimers Disease | 1 | 2021 |
| R21AG067755 | Alzheimer’s Disease Biomarker for Diagnosis and Prognosis | 1 | 2021 |
| R21AG069229 | Intranasal TIDM peptide for tauopathy | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/grants?page=54